IP Verse

Novel Pharmaceutical Formulation Comprising Dual Nk-1/Nk-3 Receptor Antagonists - EP3765024

The patent EP3765024 was granted to Kandy Therapeutics on Nov 22, 2023. The application was originally filed on Mar 13, 2019 under application number EP19711866A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3765024

KANDY THERAPEUTICS
Application Number
EP19711866A
Filing Date
Mar 13, 2019
Status
Granted And Under Opposition
Oct 20, 2023
Grant Date
Nov 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AERAAug 5, 2024ADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS8093242
DESCRIPTIONWO2007028654
DESCRIPTIONWO2011023733
DESCRIPTIONWO2016184829
INTERNATIONAL-SEARCH-REPORTWO2011023733

Non-Patent Literature (NPL) Citations (2) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BERTRAND; GEPPETTI, Trends Pharmacol. Sci., (19960000), vol. 17, pages 255 - 259-
DESCRIPTION- J.P.STANLEY, the Theory and Practice of Industrial Pharmacy, (19860000), pages 398 - 412-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents